omega-n-methylarginine has been researched along with phenoxodiol in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (phenoxodiol) | Trials (phenoxodiol) | Recent Studies (post-2010) (phenoxodiol) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 67 | 6 | 27 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | phenoxodiol (IC50) |
---|---|---|---|
Estrogen receptor | Rattus norvegicus (Norway rat) | 0.6607 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boak, L; Chin-Dusting, JP; Husband, A; Nestel, PJ | 1 |
1 trial(s) available for omega-n-methylarginine and phenoxodiol
Article | Year |
---|---|
The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism.
Topics: Adult; Brachial Artery; Enzyme Inhibitors; Forearm; Humans; Isoflavones; Lipids; Male; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vascular Resistance; Vasodilation | 2004 |